EUVIMEDEUVIMED entdecken
Open Access

Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis

Anshika Goenka iD, Xiao Song, Deanna Tiek, Rebeca Piatniczka Iglesia, Minghui Lu, Chang Zeng, Craig Horbinski iD, Wei Zhang, Bo Hu iD, Shi-Yuan Cheng iD

Neuro-Oncology · 2023

DOI: 10.1093/neuonc/noad065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Anshika Goenka und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long noncoding RNAs (lncRNAs) regulate the etiology of complex diseases and cancers, including glioblastoma (GBM). However, lncRNA-based therapies are limited because the mechanisms of action of many lncRNAs with their binding partners are not completely understood.

Methods

We used transcriptomic and genomic data to analyze correlations between LINC02283 and PDGFRA (platelet-derived growth factor receptor A). The biological functions of the novel lncRNA were assessed in vivo using patient-derived glioma stem-like cells (GSCs), and orthotopic GBM xenografts. Immunoblotting, qRT-PCR, RNA pull down, crosslinked RNA immunoprecipitation, fluorescence in situ hybridization, and antisense oligo-mediated knockdown were performed to explore the regulation of LINC02283 on PDGFRA signaling. Expression of LINC02283 in clinical samples was assessed using pathologically diagnosed GBM patient samples.

Results

We identified a novel oncogenic lncRNA, LINC02283, that is highly expressed in the PDGFRA mutation-driven cohort of glioma patients and associated with worse prognosis. LINC02283 gene co-amplifies with the PDGFRA locus and shows high correlation with PDGFRA expression. Deprivation of LINC02283 in GSCs with PDGFRA amplification mutation, attenuated tumorigenicity and enhanced survival in orthotopic GBM xenograft models, while overexpression of LINC02283 in GSCs with wild-type PDGFRA, enhances PDGFRA signaling, and decreases survival. Further, LINC02283 interacts with PDGFRA to enhance its signaling and that of its downstream targets AKT and ERK, thus promoting oncogenesis in GBM.

Conclusions

Our results provide strong evidence of LINC02283 as a regulator of PDGFRA oncogenic activity and GBM malignancy and support the potential of lncRNAs as possible therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaRNA, Long NoncodingGliomaBrain NeoplasmsHumansIn Situ Hybridization, FluorescenceCell Transformation, NeoplasticReceptors, Platelet-Derived Growth FactorGene Expression Regulation, NeoplasticCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

PDGFRAco-amplificationglioblastomalncRNAsignaling

Substanzen

RNA, Long NoncodingReceptors, Platelet-Derived Growth Factor

Autor:innen und Institutionen

  • The Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • The Lou and Jean Malnati Brain Tumor Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Department of Neurology, Chicago, Illinois, USA.
  • Master of Biotechnology Program, Northwestern University, Evanston, Illinois, USA.
  • Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Preventive Medicine, Chicago, Illinois, USA.

ORCID-Profile: Anshika Goenka, Craig Horbinski, Bo Hu, Shi-Yuan Cheng

Förderung

  • NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • Lou and Jean Malnati Brain Tumor Institute at Northwestern Medicine
  • United States Army Medical Research Acquisition Activity
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Cancer Institute

Zitieren

APA

Goenka, A., Song, X., Tiek, D., Iglesia, R. P., Lu, M., Zeng, C., Horbinski, C., Zhang, W., Hu, B., & Cheng, S. Y. (2023). Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad065

Vancouver

Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, et al. Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad065

BibTeX
@article{Goenka2023,
  author = {Goenka, Anshika and Song, Xiao and Tiek, Deanna and Iglesia, Rebeca Piatniczka and Lu, Minghui and Zeng, Chang and Horbinski, Craig and Zhang, Wei and Hu, Bo and Cheng, Shi-Yuan},
  title = {Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis},
  journal = {Neuro-Oncology},
  year = {2023},
  doi = {10.1093/neuonc/noad065}
}
Kostenlos starten →